In the Media

November 1, 2018

Video: InMed CEO Eric A. Adams – how InMed is different from competitors

In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.

InMed does not grow cannabis. We biosynthesize the compounds in a lab.
InMed products do not contain THC.
InMed products are applied topically.

Source: BTV

Share this post

Latest Articles

Current research into the potential therapeutic effects of cannabinol (CBN)

How do cannabinoids interact with the human body? There has been a significant growth in interest and research into the potential therapeutic properties of cannabinoids.

April 8, 2021

InMed’s CEO Eric A. Adams presents at Edison Open House: Global Healthcare 2021

InMed Pharmaceuticals CEO, Eric A. Adams, is interviewed by Science Journalist and Broadcaster Vivienne Parry Obe at the Edison Open House: Global Healthcare Conference 2021.

February 18, 2021

Cannabinol 101: The Science of Cannabinol (CBN)

Cannabinol, or CBN for short, is one of the more than 100 rare cannabinoids found in the Cannabis plant. CBN is found in aged Cannabis

June 8, 2020